Ivacaftor side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Ivacaftor. Common side effects include infective pulmonary exacerbation of cystic fibrosis among females, and nasopharyngitis among males.
The phase IV clinical study is created by eHealthMe based on 363 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
363 people who take Ivacaftor and have side effects are studied.
What is Ivacaftor?
Ivacaftor has active ingredients of ivacaftor. Currently, eHealthMe is studying from 363 Ivacaftor users.
Number of Ivacaftor reports submitted per year:
Ivacaftor side effects by time on the drug *:
Ivacaftor side effects by gender *:
Ivacaftor side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Ivacaftor?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on ivacaftor (the active ingredients of Ivacaftor) and Ivacaftor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Ivacaftor:
- Ivacaftor (363 reports)
All Ivacaftor side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gabapentin and Glatiramer Acetate drug interaction - now
- Baclofen and Glatiramer Acetate drug interaction - a second ago
- Hysingla Er and Kadian drug interaction - 11 seconds ago
- Ibuprofen and Tongue Disorder - 24 seconds ago
- Prednisone and Hepatic Cyst - 38 seconds ago
- Lopressor and Normodyne drug interaction - a minute ago
- Rythmol and Symbicort drug interaction - a minute ago
- Ondansetron and Sevoflurane drug interaction - a minute ago
- Lasix and Hepatic Cirrhosis - a minute ago
- Ipratropium Bromide and Osteopenia - a minute ago